John Lenard Godfrey

John Lenard Godfrey

Active Director Director DIN 08368618
DIN 08368618 First appointment Feb 2019 Primary industry Service
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About John Lenard Godfrey

Data last updated:

John Lenard Godfrey is a Director at Galilcon Pharmaceuticals Private Limited (since 2019). The company operates in Service.

DIN 08368618
Primary Designation Director
Industry Service
First Appointment 20 Feb 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Feb 20192019Active

Directorship timeline

Open interactive timeline →
Galilcon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for John Lenard Godfrey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about John Lenard Godfrey

John Lenard Godfrey currently holds 1 directorship: Galilcon Pharmaceuticals Private Limited (Director, since 20 Feb 2019).

John Lenard Godfrey was first appointed on 20 Feb 2019 as Director at Galilcon Pharmaceuticals Private Limited.

The current boards of John Lenard Godfrey's companies include Jay Kumar Choudhary (Galilcon Pharmaceuticals Private Limited), Shakun Choudhary (Galilcon Pharmaceuticals Private Limited), Vinay Choudhary (Galilcon Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available